These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 396766)

  • 1. Antitoxic immunity against the so-called lung toxin produced by Escherichia coli.
    Emödy L; Kétyi I; Kuch B; Pácsa S
    Acta Microbiol Acad Sci Hung; 1979; 26(3):233-9. PubMed ID: 396766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An altered heart-labile enterotoxin (LT') produced by Escherichia coli serogroup O55 strain.
    Kétyi I; Emödy L; Pácsa S; Vertényi A; Kontrohr T
    Acta Microbiol Acad Sci Hung; 1979; 26(3):255-62. PubMed ID: 396768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse lung oedema caused by a toxic substance of Escherichia coli strains.
    Kétyi I; Emödy L; Kontrohr T; Vertényi A; Pácsa S; Avdeeva TA; Safonova NV; Golutova NK
    Acta Microbiol Acad Sci Hung; 1978; 25(4):307-17. PubMed ID: 382757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual antigenic composition of an Arizona strain.
    Barber C
    Microbios; 1980; 27(109 110):145-9. PubMed ID: 6160372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pasteurella haemolytica cytotoxin: production by recognized serotypes and neutralization by type-specific rabbit antisera.
    Shewen PE; Wilkie BN
    Am J Vet Res; 1983 Apr; 44(4):715-9. PubMed ID: 6869971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a non toxic chimeric protein (L1-L2-B) of Haemolysin BL from Bacillus cereus and its application in HBL toxin detection.
    Kumar TD; Murali HS; Batra HV
    J Microbiol Methods; 2008 Dec; 75(3):472-7. PubMed ID: 18718851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of antisera against homologous and heterologous Escherichia coli of porcine origin.
    Enweani CC; Gyles CL; Barnum DA
    Can J Comp Med; 1975 Jan; 39(1):54-61. PubMed ID: 46176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli.
    Talbot UM; Paton JC; Paton AW
    Infect Immun; 2005 Jul; 73(7):4432-6. PubMed ID: 15972544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin.
    Canvin JR; Paton JC; Boulnois GJ; Andrew PW; Mitchell TJ
    Microb Pathog; 1997 Mar; 22(3):129-32. PubMed ID: 9075215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 12. E. coli antibodies do not cause false-positivity in recombinant anti-HIV assays.
    Ujhelyi E; Illei G; Böhm U; Füst G; Dierich MM; Szelényi J; Merétey K; Hofbauer J; Hollán SR
    Haematologia (Budap); 1990; 23(1):3-7. PubMed ID: 2204595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    McCabe WR
    J Immunol; 1972 Mar; 108(3):601-10. PubMed ID: 4622185
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralisation of immunologically distinct staphylococcal delta haemolysins by antibodies.
    Turner WH; Pickard DJ
    J Med Microbiol; 1980 Feb; 13(1):151-3. PubMed ID: 6965729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titration of enteropathogenic Escherichia coli 334 enterotoxin preparation with homologous as well as heterologous antisera in infant mice.
    Singh A; Mohan KS; Sethi SK; Vadehra DV
    Indian J Exp Biol; 1977 Jul; 15(7):544-6. PubMed ID: 340381
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of antibody to staphylococcal delta-haemolysin in the rabbit.
    Heatley NG
    Br J Exp Pathol; 1977 Aug; 58(4):400-11. PubMed ID: 410429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
    Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
    BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological differences between verocytotoxin 2 and shiga-like toxin II.
    Head SC; Karmali MA; Roscoe ME; Petric M; Strockbine NA; Wachsmuth IK
    Lancet; 1988 Sep; 2(8613):751. PubMed ID: 2901605
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii.
    Eberspächer B; Hugo F; Pohl M; Bhakdi S
    J Med Microbiol; 1990 Nov; 33(3):165-70. PubMed ID: 2250286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.